Technical Analysis for ORINF - Orion Oyj

Grade Last Price % Change Price Change
grade A 44.6455 3.35% 1.4455
ORINF closed up 3.35 percent on Tuesday, December 3, 2019, on 2.75 times normal volume. The bulls were able to push the stock to a new 52-week high.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up
See historical ORINF trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week High Strength 0.00%
Gapped Up Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
New 52 Week Closing High Bullish 3.35%
Narrow Range Bar Range Contraction 3.35%
New 52 Week High Strength 3.35%
Gapped Up Strength 3.35%
Older signals for ORINF ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Orion Oyj engages in the development and manufacture of pharmaceuticals, active pharmaceutical ingredients (APIs), and diagnostic tests worldwide. The company operates in two segments, Pharmaceuticals and Diagnostics. The Pharmaceuticals segment develops, manufactures, and markets pharmaceuticals and APIs. This segment provides proprietary drugs in the areas of central nervous system, oncology and critical care, and pulmonary care; generic prescription drugs, as well as self-care products, such as non-prescription medicines, basic ointments, and vitamins; proprietary and generic veterinary drugs; and APIs for generic and proprietary drugs, as well as offers contract manufacturing services for APIs. This segment also markets and sells veterinary drugs manufactured by other international companies. The Diagnostics segment develops, manufactures, and markets in vitro diagnostic test systems and tests for diagnosing diseases and monitoring treatment efficacy. Orion Oyj has a strategic alliance with Novan, Inc. to manufacture topical nitric oxide-releasing product candidates; and research collaboration with Fifth Corner Inc. to seek solutions to improve the quality of life of prostate cancer patients. The company was founded in 1917 and is headquartered in Espoo, Finland.
Health Pharmaceuticals Pharmaceutical Industry Diseases Medication Pharmaceutical Industry In China Pharmaceuticals Policy Prostate Cancer Active Pharmaceutical Ingredients Diagnostic Tests Self Care Markets Pharmaceuticals Offers Contract Manufacturing Services Orion Oyj

Is ORINF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 44.6455
52 Week Low 33.2
Average Volume 436
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 0.0000
10-Day Moving Average 38.0586
Average True Range 0.0000
ADX 0.0
+DI 0.0000
-DI 0.0000
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0000
Lower Bollinger Band 0.0000
Percent B (%b) 0.0
BandWidth 0.0000
MACD Line 0.5499
MACD Signal Line 0.1100
MACD Histogram 0.4399
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 44.6455
Resistance 3 (R3) 44.6455 44.6455 44.6455
Resistance 2 (R2) 44.6455 44.6455 44.6455 44.6455
Resistance 1 (R1) 44.6455 44.6455 44.6455 44.6455 44.6455
Pivot Point 44.6455 44.6455 44.6455 44.6455 44.6455
Support 1 (S1) 44.6455 44.6455 44.6455 44.6455 44.6455
Support 2 (S2) 44.6455 44.6455 44.6455 44.6455
Support 3 (S3) 44.6455 44.6455 44.6455
Support 4 (S4) 44.6455